Healthcare on the Hill - A Look at the Creating and Restoring Equal Access To Equivalent Samples Act of 2017 (S.974)

The “Creating and Restoring Equal Access To Equivalent Samples Act of 2017” or the “CREATES Act of 2017” is a bill in the Senate that is intended to expedite the development of generic alternatives in situations where the license holders (owners of the name brand drug) may be preventing would-be generic developers from obtaining sufficient quantities of a drug for testing.